Gilead Sciences
A Pathologist at Gilead's Research Pathobiology Department supports drug development for oncology and inflammation programs by providing expertise on tissue-based endpoints, therapeutic target validation, and preclinical models. The role involves cross-functional partnerships to integrate emerging technologies and apply scientific knowledge to specific program needs for discovery and research.
Headquarters
Foster City, California, United States
Company Size
10001+ employees
Founded
1987
Gilead Sciences is a biopharmaceutical company dedicated to transforming patient care by advancing therapeutics in areas like HIV, liver disease, cancer, and inflammation. With a strong commitment to innovation, Gilead leads in the research and development of new medicines, aiming to make the world a healthier place. Their portfolio includes breakthrough therapies and ongoing advancements across multiple therapeutic areas, supported by a robust pipeline of clinical trials. Gilead is recognized for its contributions to public health and its efforts to improve access to vital medications.
Franklin Resources Inc. Decreases Stake in Gilead Sciences, Inc. $GILD
4 hours ago
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum And Mixed Fair Value Signals
1 hour ago
Jefferies initiates Gilead Sciences stock with buy rating
2 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Gilead Sciences.
41% above the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
2 days ago
Pathobiology Specialist/Research Associate III
Dawar Consulting
Discovery Scientists, in vitro and in vivo Pharmacology, in Cardiovascular & Metabolic Disease Research
Roche
Senior Director, Small Molecule Drug Discovery in Inflammation Discovery
Amgen
Faculty Position - Department of Pathology, Comparative Pathologist
St. Jude Children's Research Hospital
Discovery Scientist in Cardiovascular & Metabolism Preclinical Research -2 years temporary contract
Roche
Director, Discovery Oncology, Reverse Translation
MSD